Literature DB >> 15353367

Virulence factors of the group A streptococci and genes that regulate their expression.

Wayne Hynes1.   

Abstract

Group A streptococci produce a wide variety of extracellular (cell-associated and released) virulence factors. The function of these factors varies and includes roles in adhesion, spreading, tissue destruction, immune system evasion, and cell toxicity. How these factors are regulated with regard to one another is important for this organism s ability to bring about the variety of diseases this microbe is capable of causing. Therefore, along with the multitude of virulence factors, there are a number of regulatory systems that regulate, either directly or indirectly, the production of these factors and therefore influence the pathogenesis of group A streptococcal infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353367     DOI: 10.2741/1491

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  17 in total

1.  Regulation of virulence gene expression in Streptococcus pyogenes: determinants of differential mRNA decay.

Authors:  Julia V Bugrysheva; June R Scott
Journal:  RNA Biol       Date:  2010-09-01       Impact factor: 4.652

2.  Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone.

Authors:  Andrew Hollands; Morgan A Pence; Anjuli M Timmer; Sarah R Osvath; Lynne Turnbull; Cynthia B Whitchurch; Mark J Walker; Victor Nizet
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

3.  Role of hyaluronidase in subcutaneous spread and growth of group A streptococcus.

Authors:  Clarise Rivera Starr; N Cary Engleberg
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Long-term survival of Streptococcus pyogenes in rich media is pH-dependent.

Authors:  Dragutin J Savic; William M McShan
Journal:  Microbiology (Reading)       Date:  2012-02-23       Impact factor: 2.777

5.  Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infection.

Authors:  Morag R Graham; Kimmo Virtaneva; Stephen F Porcella; Donald J Gardner; R Daniel Long; Diane M Welty; William T Barry; Claire A Johnson; Larye D Parkins; Fred A Wright; James M Musser
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

6.  Mode of expression and functional characterization of FCT-3 pilus region-encoded proteins in Streptococcus pyogenes serotype M49.

Authors:  Masanobu Nakata; Thomas Köller; Karin Moritz; Deborah Ribardo; Ludwig Jonas; Kevin S McIver; Tomoko Sumitomo; Yutaka Terao; Shigetada Kawabata; Andreas Podbielski; Bernd Kreikemeyer
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

7.  Protective mechanisms of respiratory tract Streptococci against Streptococcus pyogenes biofilm formation and epithelial cell infection.

Authors:  Tomas Fiedler; Catur Riani; Dirk Koczan; Kerstin Standar; Bernd Kreikemeyer; Andreas Podbielski
Journal:  Appl Environ Microbiol       Date:  2012-12-14       Impact factor: 4.792

8.  vfr, a novel locus affecting cysteine protease production in Streptococcus pyogenes.

Authors:  Yongsheng Ma; Amy E Bryant; Dan B Salmi; Eric McIndoo; Dennis L Stevens
Journal:  J Bacteriol       Date:  2009-03-06       Impact factor: 3.490

9.  The Streptococcus pyogenes serotype M49 Nra-Ralp3 transcriptional regulatory network and its control of virulence factor expression from the novel eno ralp3 epf sagA pathogenicity region.

Authors:  Bernd Kreikemeyer; Masanobu Nakata; Thomas Köller; Hendrikje Hildisch; Vassilios Kourakos; Kerstin Standar; Shigetada Kawabata; Michael O Glocker; Andreas Podbielski
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

10.  Portrait of an enzyme, a complete structural analysis of a multimodular {beta}-N-acetylglucosaminidase from Clostridium perfringens.

Authors:  Elizabeth Ficko-Blean; Katie J Gregg; Jarrett J Adams; Jan-Hendrik Hehemann; Mirjam Czjzek; Steven P Smith; Alisdair B Boraston
Journal:  J Biol Chem       Date:  2009-02-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.